Zhongyuan Xu

A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor

Weitao Shen, Xuyao Zhang, Xiang Fu et al. · Cell Death and Disease · 2017 · 79 citations · Full text

Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors

Miao‐Zhen Qiu, Yang Zhang, Ye Guo et al. · JAMA Oncology · 2022 · 62 citations · Full text

Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling

Peng Zhu, Jianqiang Qian, Zhongyuan Xu et al. · Journal of Natural Products · 2020 · 38 citations · Full text

A Population-Based Study on Liver Metastases in Women with Newly Diagnosed Breast Cancer

Jingjing Xie, Zhongyuan Xu · Cancer Epidemiology Biomarkers & Prevention · 2018 · 37 citations

Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy

Boyang Zhang, Jiajun Fan, Xuyao Zhang et al. · Applied Microbiology and Biotechnology · 2016 · 33 citations

Cell Autophagy, Autophagy, Pulmonary Adenocarcinoma Therapy +5